Meclizine hydrochloride 50 MG Chewable Tablet — RxCUI 2632643
RxNorm drug concept · Semantic clinical drug
RxCUI 2632643
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2632643
Official nameMeclizine hydrochloride 50 MG Chewable Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmeclizine HCl 50 MG Chewable Tablet
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Meclizine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Meclizine is mainly used to prevent and treat the nausea, vomiting, and dizziness that comes with motion sickness — whether you're on a boat, in a car, or on a plane. It's also use...
- For the best chance of preventing motion sickness, take meclizine about one hour before you start traveling. After that first dose, you can take it once every 24 hours as needed fo...
- Yes, drowsiness is the most common side effect — it's actually worth planning around. Avoid driving or operating heavy machinery until you know how it affects you. And definitely s...
- This one requires a conversation with your doctor. Human studies haven't clearly linked meclizine to birth defects, but animal studies did show fetal harm at doses similar to what...
🕸️ Concept Web — How Meclizine hydrochloride 50 MG Chewable Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Meclizine hydrochloride 50 MG Chewable Tablet
RxCUI 2632643 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Meclizine
6676IN -
Meclizine hydrochloride
82041PIN
-
Meclizine
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Meclizine Chewable Tablet
372730SCDF -
Meclizine hydrochloride Chewable Tablet
2646959SCDFP -
Meclizine Chewable Product
1295409SCDG -
Meclizine Oral Product
1159177SCDG -
Meclizine Pill
1159178SCDG -
Meclizine hydrochloride Chewable Product
2663038SCDGP -
Meclizine hydrochloride Oral Product
2659152SCDGP -
Meclizine hydrochloride Pill
2660116SCDGP - +4 more in this family
-
Meclizine Chewable Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Meclizine hydrochloride 50 MG
995685SCDC
-
Meclizine hydrochloride 50 MG
Showing up to 8 concepts per family — 11 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Meclizine hydrochloride 50 MG
SCDC · 995685 -
Meclizine Chewable Tablet
SCDF · 372730 -
Meclizine hydrochloride Chewable Tablet
SCDFP · 2646959 -
Meclizine Chewable Product
SCDG · 1295409 -
Meclizine Oral Product
SCDG · 1159177 -
Meclizine Pill
SCDG · 1159178 -
Meclizine hydrochloride Chewable Product
SCDGP · 2663038 -
Meclizine hydrochloride Oral Product
SCDGP · 2659152 -
Meclizine hydrochloride Pill
SCDGP · 2660116
📦 FDA Products & Package NDCs
1 product · 2 package NDCs
2 package NDCs map to RxCUI 2632643 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 65197-0520-16 | 2 BLISTER PACK in 1 BOX (65197-520-16) / 8 TABLET, CHEWABLE... | BONINE MAX | WellSpring Pharmaceutical Corporation | 2023-03-24 |
| 65197-0520-17 | 2 BLISTER PACK in 1 BOX (65197-520-17) / 8 TABLET, CHEWABLE... | BONINE MAX | WellSpring Pharmaceutical Corporation | 2025-04-15 |
Observed labelers:
WellSpring Pharmaceutical Corporation (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.